<DOC>
	<DOCNO>NCT02120560</DOCNO>
	<brief_summary>Atrial fibrillation ( AF ) common cardiac arrhythmia United States , treatment AF ablation quickly become favor definitive therapy . Nonetheless , AF ablation come risk , include bleeds related vascular access myocardial damage , well rare incidence clinical stroke blood clot travel heart brain , term `` cerebrothromboemboli . '' In fact , cerebrothromboemboli without symptom detect special imaging procedure call brain magnetic resonance imaging ( MRI ) many 22 % case . ( 1-6 ) There remain clinical equipoise amongst expert regard balance risk benefit continue versus interrupt blood thinning , `` anticoagulation '' AF ablation pertain risk bleed cerebrothromboemboli prevention , respectively , potentially subtle sequela apparently silent cerebrothromboemboli remain unknown . In fact , interruption continuation anticoagulation AF ablation standard care . The investigator perform first randomize trial uninterrupted versus interrupt anticoagulation patient undergo AF ablation determine mitigate neurologic injury . The objective research investigate effect continue anticoagulation AF ablation cerebrothromboemboli , neurocognitive sequela embolic lesion , point consider subclinical . The investigator hypothesize continued anticoagulation reduce cerebrothromboemboli mitigate potential decline neurocognitive function post-procedurally . The investigator also hypothesize incidence cerebrothromboemboli ( CTE ) MRI mediate difference .</brief_summary>
	<brief_title>Anticoagulation AF Ablation Effects Neurocognitive Function</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients 18 year old old AF ( paroxysmal persistent ) undergo elective AF ablation procedure UCSF eligible enrollment . Patients exclude : A contraindication warfarin therapy ( pregnancy , recent bleed , inability serial INR check ) A contraindication relative contraindication interruption anticoagulation ( e.g . mechanical valve , clot disorder antiphospholipid syndrome , recent history pulmonary embolism history recurrent pulmonary embolism ) A contraindication transesophageal echocardiogram ; contraindication MRI Have diagnose condition dementia diagnosis precludes accurate assessment neurocognitive function NonEnglish speaker Inability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Atrial Fibrillation Ablation</keyword>
	<keyword>Cerebrothromboemboli</keyword>
	<keyword>Neurocognitive Function</keyword>
</DOC>